El-Bondkly A M, Abd-Alla Howaida I, Shaaban M, Shaaban K A
Indian J Pharm Sci. 2008 May-Jun;70(3):310-9. doi: 10.4103/0250-474X.42979.
In our ongoing search for production improvements of bioactive secondary metabolites from marine Streptomyces through the induction of mutations using UV light, out of 145 isolates, mutant 10/14 was able to produce potent antibacterial metabolites other than the parent strain as established by chromatographic analysis. Up-scaling fermentation of mutant 10/14, followed by working up and isolation delivered five metabolites, phenazine, 1-acetyl-beta -carboline, perlolyrin and erythromycin A, along with an oily substance. The latter two compounds were responsible for the antibacterial activity of the strain. In this article, we discuss with the mutation of the marine Streptomyces sp. AH2, bioactivity evaluation, fermentation and isolation of the microbial metabolites. Moreover, we study to first time in detail the 1D and 2D NMR and ESI MS data including ESI MS(2) and MS(3) patterns combined with HRESI MS of erythromycin A.
在我们通过紫外线诱导突变来持续寻求提高海洋链霉菌生物活性次生代谢产物产量的过程中,在145个分离株中,经色谱分析确定,突变体10/14能够产生除亲本菌株之外的强效抗菌代谢产物。对突变体10/14进行放大发酵,随后进行后处理和分离,得到了五种代谢产物,吩嗪、1-乙酰基-β-咔啉、紫苏素和红霉素A,以及一种油性物质。后两种化合物是该菌株抗菌活性的原因。在本文中,我们讨论了海洋链霉菌AH2的突变、微生物代谢产物的生物活性评估、发酵和分离。此外,我们首次详细研究了一维和二维核磁共振以及电喷雾电离质谱数据,包括红霉素A的电喷雾电离质谱(2)和质谱(3)图谱以及高分辨电喷雾电离质谱。